Products Catalog

Specification

FULVESTRANT
MF C32H47F5O3S
MW 606.77
CAS 129453-61-8
Assay: 99%
Appearance : White fine powder
Category: Intermediates & Fine Chemicals; Pharmaceuticals
Package 25kg/ bag
Usage Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor.[ 1] It is administered as a once-monthly injection.